RAPT Therapeutics (RAPT) Profit After Tax: 2018-2023
Historic Profit After Tax for Therapeutics (RAPT) over the last 6 years, with Dec 2023 value amounting to -$116.8 million.
- Therapeutics' Profit After Tax fell 34.54% to -$30.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$116.8 million, marking a year-over-year decrease of 39.32%. This contributed to the annual value of -$116.8 million for FY2023, which is 39.32% down from last year.
- Per Therapeutics' latest filing, its Profit After Tax stood at -$116.8 million for FY2023, which was down 39.32% from -$83.8 million recorded in FY2022.
- Therapeutics' Profit After Tax's 5-year high stood at -$43.0 million during FY2019, with a 5-year trough of -$116.8 million in FY2023.
- In the last 3 years, Therapeutics' Profit After Tax had a median value of -$83.8 million in 2022 and averaged -$89.9 million.
- Data for Therapeutics' Profit After Tax shows a maximum YoY tumbled of 39.32% (in 2023) over the last 5 years.
- Over the past 5 years, Therapeutics' Profit After Tax (Yearly) stood at -$43.0 million in 2019, then dropped by 23.01% to -$52.9 million in 2020, then tumbled by 30.84% to -$69.2 million in 2021, then fell by 21.15% to -$83.8 million in 2022, then tumbled by 39.32% to -$116.8 million in 2023.